Predictors of Ischemic Cardiomyopathy in Patients with Acute Myocardial Infarction who Underwent Percutaneous Coronary Intervention

Hye Sook Kim(Myongji Hospital), Jong-Chun Park(Pusan National University), Yongcheol Kim(Severance Hospital), Kye Hun Kim(Chonnam National University), Doo Sun Sim(Chonnam National University Hospital), Ju Han Kim(Chonnam National University), Youngkeun Ahn(Chonnam National University Hospital), Jae Young Cho(Wonkwang University Hospital), Min Chul Kim(Chonnam National University), Myung Ho Jeong(Veterans Health Service Medical Center), Hyun Ju Yoon(Chonnam National University Hospital), Young Joon Hong(Chonnam National University Hospital), Seok‐Joon Sohn
Korean Journal of Medicine
June 1, 2020
10.3904/kjm.2020.95.3.188
Cited by 1

Related Papers

Mesenchymal stem cells reciprocally regulate the M1/M2 balance in mouse bone marrow-derived macrophages
|Experimental & Molecular Medicine|2014|548
Effect of Ticagrelor Monotherapy vs Ticagrelor With Aspirin on Major Bleeding and Cardiovascular Events in Patients With Acute Coronary Syndrome
|JAMA|2020|548
Randomized Trial Evaluating Percutaneous Coronary Intervention for the Treatment of Chronic Total Occlusion
|Circulation|2019|398
Unguided de-escalation from ticagrelor to clopidogrel in stabilised patients with acute myocardial infarction undergoing percutaneous coronary intervention (TALOS-AMI): an investigator-initiated, open-label, multicentre, non-inferiority, randomised trial
|The Lancet|2021|202
Circadian rhythm of hyperoxidized peroxiredoxin II is determined by hemoglobin autoxidation and the 20S proteasome in red blood cells
|Proceedings of the National Academy of Sciences|2014|132